Form 4 for QURE uniQure N.V.
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-06 · accession 0000904454-25-000568 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-10 | 2025-11-06 | QURE | Gut Robert | Dir | S - Sale+OE | $27.26 | -31.4K | 40.1K | -44% | -$856.9K |
| D | 2025-11-10 | 2025-11-06 | QURE | Gut Robert | Dir | M - OptEx | $4.57 | +15.8K | 71.6K | +28% | +$72.4K |
| D | 2025-11-10 | 2025-11-06 | QURE | Gut Robert | Dir | M - OptEx | $0.00 | -15.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-11-06 | S | D | 15,840 | $27.22 | 55,739 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.00 to $27.38. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares | 2025-11-06 | S | D | 15,594 | $27.30 | 40,145 | D | — | — | |
| 3 | Common | Ordinary Shares | 2025-11-06 | M | A | 15,840 | $4.57 | 71,579 | D | — | — | (F2) Adjusted to reflect (i) the sale of 1,120 shares under the Reporting Person's 10b5-1 plan on June 23, 2020, which was inadvertently omitted from the Form 4 filed on June 24, 2020, and (ii) the correction to a typographical error in the number of shares sold by the Reporting Person on June 13, 2024 reported on the Form 4 filed on June 17, 2024. The Form 4 reported the sale of 3,504 shares but should have reported the sale of 3,524 shares. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-11-06 | M | D | 15,840 | $0.00 | 0 | D | $4.57 · — to 2034-06-19 | 15,840 Ordinary Shares | (F4) The Stock Option vested in full on June 19, 2025. |